Inventor profile of:

John Flanagan

City:

East Windsor, New Jersey

Country:

United States

Published Applications:

16

Last publication date:

2026-03-26

Top Assignees for applications by John Flanagan

The entities that hold a legal rights for patent applications filed by inventor Flanagan John:

Recent patent applications by Flanagan John

John Flanagan from East Windsor, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-03-26
US20260083829A1
Human necessities

High Concentration Alpha-Glucosidase Compositions For The Treatment Of Pompe Disease

#2 | 2025-03-13
US20250082621A9
Human necessities

Method To Predict Response To Pharmacological Chaperone Treatment Of Diseases

#3 | 2022-11-03
US20220347272A1
Human necessities

HIGH CONCENTRATION ALPHA-GLUCOSIDASE COMPOSITIONS FOR THE TREATMENT OF POMPE DISEASE

#4 | 2021-08-19
US20210251971A1
Human necessities

Method To Predict Response To Pharmacological Chaperone Treatment Of Diseases

#5 | 2020-06-18
US20200188494A1
Human necessities

High concentration alpha-glucosidase compositions for the treatment of Pompe disease

#6 | 2019-01-03
US20190000818A1
Human necessities

Method to predict response to pharmacological chaperone treatment of diseases

#7 | 2018-12-20
US20180360928A1
Human necessities

High concentration alpha-glucosidase compositions for the treatment of pompe disease

#8 | 2017-03-02
US20170056483A1
Human necessities

High concentration alpha-glucosidase compositions for the treatment of Pompe disease

#9 | 2017-01-05
US20170003301A1
Physics

METHOD TO PREDICT RESPONSE TO PHARMACOLOGICAL CHAPERONE TREATMENT OF DISEASES

#10 | 2015-12-03
US20150342940A1
Human necessities

Method to predict response to pharmacological chaperone treatment of diseases

#11 | 2015-02-12
US20150044194A1
Chemistry; metallurgy

High concentration alpha-glucosidase compositions for the treatment of Pompe disease

#12 | 2014-07-24
US20140206721A1
Human necessities

Method to predict response to pharmacological chaperone treatment of diseases

#13 | 2014-07-10
US20140193390A1
Human necessities

High concentration α-glucosidase compositions for the treatment of Pompe disease

#14 | 2012-04-05
US20120083010A1
Chemistry; metallurgy

METHOD FOR DIAGNOSING POMPE DISEASE

#15 | 2011-09-01
US20110212996A1
Human necessities

Method to predict response to pharmacological chaperone treatment of diseases

#16 | 2011-06-23
US20110152319A1
Chemistry; metallurgy

METHOD TO PREDICT RESPONSE TO PHARMACOLOGICAL CHAPERONE TREATMENT OF DISEASES

InventorID:

831779 ⎘